Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Q2 Revenues Shrink 8 Percent

NEW YORK (GenomeWeb) – Danish miRNA biomarker firm Exiqon reported today an 8 percent decrease year over year in its second quarter revenues.

For the three months ended June 30, revenues totaled DKK 30.7 million ($5.5 million), down from DKK 33.3 million in the year-ago period. The firm said research product sales and services declined 3 percent year over year to DKK 24.9 million in the quarter, while service revenues fell 10 percent to DKK 3.7 million.

Exiqon did not break out the rest of its revenues for the quarter.

The company recorded a net loss of DKK 1.2 million, or DKK .03 per share, in the quarter, compared to a loss of DKK 1.3 million, or DKK .03 per share, a year ago.

Its R&D costs rose 16 percent year over year to DKK 6.5 million from DKK 5.6 million, and its SG&A spending was down almost 6 percent to DKK 15.3 million from DKK 16.2 million.

As of June 30, Exiqon had DKK 23.1 million in cash and cash equivalents.

The firm lowered its revenue outlook for full-year 2014 to DKK 135 million from a previous figure of DKK 150 million.

In a statement, Exiqon CEO Lars Kongsbak said, "Towards [the] end of the second quarter we have witnessed an accumulation of large orders, and we expect renewed growth in products and services sales will come from new products once our recent growth initiatives begin to take effect in the second half year."

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.